Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Hypoxemic respiratory failure in a 57-year-old woman with acute monocytic leukemia.

Valentino DJ 3rd, Gelfand MC, Nava VE, Garvin DF, Roberts AH 2nd.

Chest. 2005 Nov;128(5):3629-33. No abstract available. Erratum in: Chest. 2006 Jan;129(1):216.

PMID:
16304323
2.

QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report.

Hodak SP, Moubarak JB, Rodriguez I, Gelfand MC, Alijani MR, Tracy CM.

Transplantation. 1998 Aug 27;66(4):535-7.

PMID:
9734501
3.

Polycystic kidneys do maintain good endocrine function.

Rotellar C, Gelfand MC.

Med Hypotheses. 1989 Sep;30(1):61-4.

PMID:
2796810
4.

Exophthalmos: rare complication of A-V fistula used for hemodialysis.

Rotellar C, Gelfand MC, Knepshield JH.

Nephron. 1987;45(1):78. No abstract available.

5.

Plasmapheresis related to organ transplantation.

Gurland HJ, Vangelista A, Fassbinder W, Gelfand MC, Bensinger WI.

Life Support Syst. 1985;3 Suppl 1:334-41. No abstract available.

PMID:
3916612
6.

Captopril-associated cholestatic jaundice.

Rahmat J, Gelfand RL, Gelfand MC, Winchester JF, Schreiner GE, Zimmerman HJ.

Ann Intern Med. 1985 Jan;102(1):56-8.

PMID:
3881069
7.

Ontogeny and localization of the IgG Fc receptor of rabbit ciliary processes.

Peress NS, Medeiros-Roxburgh VA, Gelfand MC.

Exp Eye Res. 1984 Sep;39(3):325-33.

PMID:
6238837
8.

Plasmaleukapheresis decreases fibronectin and alpha-1-antitrypsin concentrations in patients with acute renal transplant rejection.

Gelfand MC, Meikka S, McLaughlin PA, Sacher R, Peters S, Helfrich GB.

Trans Am Soc Artif Intern Organs. 1984;30:244-7. No abstract available.

PMID:
6398546
9.

Early indicators of renal allograft rejection.

Winchester JF, Gelfand MC, Foegh ML, Helfrich GB, Schreiner GE.

Kidney Int Suppl. 1983 May;(14):S-34-40. Review. No abstract available.

PMID:
6224041
10.

Extracorporeal immunomodulation (EIM) by plasmaleukapheresis (PLP) in the treatment of steroid resistant renal rejection.

Gelfand MC, Helfrich GB, Peters SM, Sacher RA, McLaughlin PA, Melhorn NL, Phillips T, Schreiner GE.

Trans Am Soc Artif Intern Organs. 1983;29:339-43.

PMID:
6369728
11.

Binding sites for immunoglobulin G in rabbit ciliary processes.

Peress NS, Roxburgh VA, Gelfand MC.

Invest Ophthalmol Vis Sci. 1982 Oct;23(4):457-63.

PMID:
7118505
12.

Kyrle's disease in patients with chronic renal failure.

Hood AF, Hardegen GL, Zarate AR, Nigra TP, Gelfand MC.

Arch Dermatol. 1982 Feb;118(2):85-8. No abstract available.

PMID:
7059223
13.

Treatment of intoxication with charcoal hemadsorption.

Cohan SL, Winchester JF, Gelfand MC.

Drug Metab Rev. 1982;13(4):681-93. No abstract available.

PMID:
7128455
14.

Hemoperfusion in toxic ingestions and hepatic encephalopathy: have the expectations been achieved?

Gelfand MC.

Contrib Nephrol. 1982;29:101-13. No abstract available.

PMID:
7075211
15.

Hemosiderosis in hemodialysis patients.

Bregman H, Gelfand MC, Winchester JF, Knepshield JH.

JAMA. 1981 Jul 17;246(3):214-5. No abstract available.

PMID:
7241758
16.

Binding of IgG-sensitized erythrocytes by mitral and aortic cardiac valves: a possible clue to the pathogenesis of immune valvular heart disease.

Gelfand MC, Maclay M, Shin ML, Green I, Frank MM.

Clin Immunol Immunopathol. 1981 May;19(2):151-60. No abstract available.

PMID:
7226577
17.

Iron overload in patients on maintenance hemodialysis.

Bregman H, Gelfand MC.

Int J Artif Organs. 1981 Mar;4(2):56-7. No abstract available.

PMID:
7275332
18.

Binding sites for immune components in human choroid plexus.

Peress NS, Roxburgh VA, Gelfand MC.

Arthritis Rheum. 1981 Mar;24(3):520-6.

PMID:
7213430
19.

Extracorporeal treatment of salicylate or acetaminophen poisoning--is there a role?

Winchester JF, Gelfand MC, Helliwell M, Vale JA, Goulding R, Schreiner GE.

Arch Intern Med. 1981 Feb 23;141(3 Spec No):370-4. Review.

PMID:
7008736
20.

Hemoperfusion of poisons and drugs in children.

Jose PA, Winchester JF, Gelfand MC.

Contrib Nephrol. 1981;27:61-4. No abstract available.

PMID:
7285589
21.

Will hemoperfusion be useful for cancer chemotherapeutic drug removal?

Winchester JF, Rahman A, Tilstone WJ, Bregman H, Mortensen LM, Gelfand MC, Schein PS, Schreiner GE.

Clin Toxicol. 1980 Nov;17(4):557-69.

PMID:
7460507
22.

Hemoperfusion in drug overdosage: a technique when conservative management is not sufficient.

Gelfand MC, Winchester JF.

Clin Toxicol. 1980 Nov;17(4):583-602. Review. No abstract available.

PMID:
7006895
23.

iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder.

Bregman H, Gelfand MC, Winchester JF, Manz HJ, Knepshield JH, Schreiner GE.

Lancet. 1980 Oct 25;2(8200):882-5.

PMID:
6107546
24.

Pericardial effusion associated with minoxidil therapy in dialyzed patients.

Zarate A, Gelfand MC, Horton JD, Winchester JF, Gottlieb MJ, Lazarus JM, Schreiner GE.

Int J Artif Organs. 1980 Jan;3(1):15-7.

PMID:
7353909
25.

HLA-linked iron overload and myopathy in maintenance hemodialysis patients.

Bregman H, Gelfand MC, Winchester JF, Manz HJ, Knepshield JH.

Trans Am Soc Artif Intern Organs. 1980;26:366-8. No abstract available.

PMID:
7245514
26.

Controlled trials of hemoperfusion for intoxication.

Better OS, Brunner G, Chang TM, Courtney JM, Farrell PC, Gelfand MC, Gimson A, Gurland HJ, Hoffer E, Maeda K, Maini R, Rosenbaum JL, Sideman S, Taitleman U, Winchester JF.

Ann Intern Med. 1979 Dec;91(6):925. No abstract available.

PMID:
391120
27.

Realities in evaluating the clinical uses of sorbent hemoperfusion.

Winchester JF, Gelfand MC, Knepshield JH, Schreiner GE.

Int J Artif Organs. 1979 Nov;2(6):310-4. No abstract available.

PMID:
511372
28.

Bacteremia in the hemodialyzed patient. A persistent problem in spite of technological progress.

Gelfand MC.

Arch Intern Med. 1979 Nov;139(11):1223. No abstract available.

PMID:
508016
29.

Urinary mononuclear cell populations in renal infection and allograft rejection.

Gelfand MC, Gilad V, Lee J, Schreiner GE.

Transplant Proc. 1979 Jun;11(2):1224-5. No abstract available.

PMID:
382490
30.

Binding sites for immune complexes containing IgG in the renal interstitium.

Gelfand MC, Frank MM, Green I, Shin ML.

Clin Immunol Immunopathol. 1979 May;13(1):19-29. No abstract available.

PMID:
455796
31.

Hemoperfusion results in uremia.

Gelfand MC, Winchester JF.

Clin Nephrol. 1979 Feb;11(2):107-10. Review. No abstract available.

PMID:
378488
32.

The artificial liver - 1978.

Winchester JF, Gelfand MC.

Int J Artif Organs. 1979 Jan;2(1):3-6. No abstract available.

PMID:
500238
33.

Hemoperfusion: present and future.

Gelfand MC.

J Dial. 1979;3(1):1-9. No abstract available.

PMID:
469100
34.

Hemoperfusion in drug overdose.

Gelfand MC.

JAMA. 1978 Dec 15;240(25):2761-2. No abstract available.

PMID:
713018
35.

Hyperkaratosis penetrans (HKP): a rare dermatological disease with high incidence in patients on hemodialysis.

Zarate AR, Hood AF, Hardegen GL, Knepshield JH, Gelfand MC.

Proc Clin Dial Transplant Forum. 1978 Nov 18-20;8:99-102. No abstract available.

PMID:
756050
36.

Heparin associated hemodialysis hyperthyroidism (HHH): a physiologically significant phenomenon.

Gelfand MC, Rodelas R, McAnally JF, Novello A, Winchester JF.

Proc Clin Dial Transplant Forum. 1978 Nov 18-20;8:255-9. No abstract available.

PMID:
226951
37.

Present and future uses of hemoperfusion with sorbents.

Winchester JF, Gelfand MC, Knepshield JH, Schreiner GE.

Artif Organs. 1978 Nov;2(4):353-8. No abstract available.

PMID:
743004
38.

Overdose.

Winchester JF, Knepshield JH, Gelfand MC, Schreiner GE.

Br J Hosp Med. 1978 Jul;20(1):92. No abstract available.

PMID:
687868
39.

Biochemical correlates of reversal of hepatic coma coated with charcoal hemoperfusion.

Gelfand MC, Winchester JF, Knepshield JH, Cohan SL, Schreiner GE.

Trans Am Soc Artif Intern Organs. 1978;24:239-42.

PMID:
716005
40.

Hemoperfusion in drug intoxication: clinical and laboratory aspects.

Winchester JF, Gelfand MC, Tilstone WJ.

Drug Metab Rev. 1978;8(1):69-104. Review. No abstract available.

PMID:
363382
41.

Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.

Klassen LW, Zarate A, Gelfand MC, Steinberg AD.

J Immunol. 1977 Dec;119(6):2067-72. No abstract available.

PMID:
334981
42.

Successful management of hepatic coma by hemocarboperfusion.

Colon AR, Gelfand MC, Knepshield JH, Papadopoulou Z, Sandler P, Schreiner GE.

J Pediatr. 1977 Jun;90(6):1015-6. No abstract available.

PMID:
859050
43.

Localization of receptors for activated complement on visceral epithelial cells of the human renal glomerulus.

Shin ML, Gelfand MC, Nagle RB, Carlo JR, Green I, Frank MM.

J Immunol. 1977 Mar;118(3):869-73.

PMID:
845439
44.

Treatment of severe drug overdosage with charcoal hemoperfusion.

Gelfand MC, Winchester JF, Knepshield JH, Hanson KM, Cohan SL, Strauch BS, Geoly KL, Kennedy AC, Schreiner GE.

Trans Am Soc Artif Intern Organs. 1977;23:599-605.

PMID:
910388
45.

Natural history of asymptomatic pericardial effusions in patients on maintenance hemodialysis.

Horton JD, Gelfand MC, Sherber HS.

Proc Clin Dial Transplant Forum. 1977;7:76-81. No abstract available.

PMID:
616003
46.

Dialysis and hemoperfusion of poisons and drugs--update.

Winchester JF, Gelfand MC, Knepshield JH, Schreiner GE.

Trans Am Soc Artif Intern Organs. 1977;23:762-842. Review. No abstract available.

PMID:
333704
47.

Treatment of hepatic coma with hemoperfusion through polyacrylamide hydrogel-coated charcoal.

Gelfand MC, Knepshield JH, Cohan S, Ramirez B, Schreiner GE.

Kidney Int Suppl. 1976 Dec;(7):S239-43. No abstract available.

PMID:
1070538
48.

The glomerular complement receptor in immunologically mediated renal glomerular injury.

Gelfand MC, Shin ML, Nagle RB, Green I, Frank MM.

N Engl J Med. 1976 Jul 1;295(1):10-4.

PMID:
1272284
49.

Treatment of digitalis intoxication by charcoal hemoperfusion (CHP).

Carvallo A, Ramirez B, Honig H, Knepshield J, Schreiner GE, Gelfand MC.

Trans Am Soc Artif Intern Organs. 1976;22:718-22.

PMID:
951891
50.

Therapeutic studies in NZB/W mice. IV. Effect of combination drug therapy on immune complex deposition.

Gelfand MC, Schur PH, Asofsky R, Steinberg AD.

Arthritis Rheum. 1976 Jan-Feb;19(1):43-8.

PMID:
130136

Supplemental Content

Loading ...
Support Center